CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 192 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,638,801 | -6.5% | 55,628 | +3.5% | 0.37% | -10.3% |
Q2 2023 | $1,752,934 | -12.0% | 53,738 | -5.0% | 0.42% | -11.9% |
Q1 2023 | $1,991,191 | -26.0% | 56,584 | -3.7% | 0.47% | -25.8% |
Q4 2022 | $2,691,100 | -56.8% | 58,732 | -54.3% | 0.64% | -57.6% |
Q3 2022 | $6,225,000 | -3.1% | 128,485 | -21.5% | 1.50% | -1.1% |
Q2 2022 | $6,427,000 | +9.5% | 163,583 | +2.6% | 1.52% | +27.7% |
Q1 2022 | $5,871,000 | -15.6% | 159,498 | +4.5% | 1.19% | -18.9% |
Q4 2021 | $6,956,000 | +19.0% | 152,619 | -6.6% | 1.46% | +10.5% |
Q3 2021 | $5,843,000 | +86.3% | 163,476 | +3.1% | 1.33% | +86.8% |
Q2 2021 | $3,137,000 | -9.5% | 158,499 | +6.3% | 0.71% | -20.2% |
Q1 2021 | $3,468,000 | +9.5% | 149,084 | -2.2% | 0.89% | +2.4% |
Q4 2020 | $3,167,000 | +30.5% | 152,395 | +35.9% | 0.87% | +14.9% |
Q3 2020 | $2,427,000 | +7.2% | 112,124 | +16.7% | 0.76% | -10.7% |
Q2 2020 | $2,265,000 | +39.9% | 96,107 | -1.3% | 0.85% | +25.3% |
Q1 2020 | $1,619,000 | +48.9% | 97,354 | -5.0% | 0.68% | +54.3% |
Q4 2019 | $1,087,000 | – | 102,476 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |